Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The company is one of the best yield companies with high dividend expectations.
  • The stock is in a well-established, long-term rising trend above the technical support level at 33.92 USD
Weaknesses
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company's enterprise value to sales, at 4.57 times its current sales, is high.
  • For the last four months, EPS estimates made by Thomson-Reuters analysts have been revised downwards.
  • For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
PFIZER11.58%216 886
JOHNSON & JOHNSON23.60%382 202
NOVARTIS13.50%226 404
ROCHE HOLDING LTD.5.55%207 116
MERCK AND COMPANY7.88%174 223
AMGEN27.41%133 501
SANOFI8.99%124 704
BAYER19.94%114 930
BRISTOL-MYERS SQUIBB COMPAN..10.66%105 644
NOVO NORDISK A/S25.13%99 069
GLAXOSMITHKLINE-1.66%98 802
ABBOTT LABORATORIES45.20%97 853
ELI LILLY AND COMPANY16.56%96 039
CELGENE CORPORATION18.51%94 923
ASTRAZENECA16.62%85 977
ALLERGAN PLC-10.89%62 943
More Results
Financials ($)
Sales 2017 52 694 M
EBIT 2017 19 840 M
Net income 2017 11 410 M
Debt 2017 24 099 M
Yield 2017 3,52%
P/E ratio 2017 19,60
P/E ratio 2018 17,01
EV / Sales 2017 4,57x
EV / Sales 2018 4,38x
Capitalization 217 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart PFIZER
Duration : Period : Day
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Duration : Period : Week
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders